Form Type:  6-K
Filing Date:  6/23/2022 
CIK:  0001828253 
Address:  BREDGADE 34E 
City, State, Zip:  COPENHAGEN K,  1260 
Telephone:  (453) 126-2615 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
-0.02 (-0.71%)  
Trade Time: 
Aug 10  
Market Cap: 
Trade EVAX now with 

© 2022  
Description of Business
We are a clinical-stage AI-immunology(TM) platform company using our proprietary artificial intelligence, or AI, technology, engineering expertise and drug development know-how to simulate the human immune system and generate predictive models to identify and develop novel immunotherapies for the treatment of various cancers, bacterial diseases and viral infections. Drug discovery and clinical development using historically prevailing techniques is a long, costly process with a high attrition rate. We believe our proprietary AI-immunology platforms, trained to translate vast amounts of data into a deep understanding of biological processes in the human body, can be harnessed to rapidly and cost effectively design and develop unique immunotherapies, thereby potentially revolutionizing the process of drug discovery and development.
Register and access this filing in:     
  FORM 6-K
  EXHIBIT 99.1